Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

1,466 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

NCT01988571

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
Locations
  • Kaiser Permanente Los Angeles Medical Center Los Angeles, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
  • Northwestern University Chicago, Illinois, United States
View all 51 locations
View Trial Details
Completed

A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL)

NCT02857426

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City Of Hope Medical Center Duarte, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • H. Lee Moffitt Cancer Center & Research Inst, Inc Tampa, Florida, United States
View all 50 locations
View Trial Details
Completed

Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma

NCT01118026

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations
  • Naval Medical Center -San Diego San Diego, California, United States
  • Saint Helena Hospital St. Helena, California, United States
  • Beebe Medical Center Lewes, Delaware, United States
  • Delaware Clinical and Laboratory Physicians PA Newark, Delaware, United States
View all 55 locations
View Trial Details
Completed

S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma

NCT01412879

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 204 locations
View Trial Details
Completed

Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas

NCT03489343

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Oncology San Antonio, Texas, United States
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
View Trial Details

Related conditions